<code id='A1E8743D5C'></code><style id='A1E8743D5C'></style>
    • <acronym id='A1E8743D5C'></acronym>
      <center id='A1E8743D5C'><center id='A1E8743D5C'><tfoot id='A1E8743D5C'></tfoot></center><abbr id='A1E8743D5C'><dir id='A1E8743D5C'><tfoot id='A1E8743D5C'></tfoot><noframes id='A1E8743D5C'>

    • <optgroup id='A1E8743D5C'><strike id='A1E8743D5C'><sup id='A1E8743D5C'></sup></strike><code id='A1E8743D5C'></code></optgroup>
        1. <b id='A1E8743D5C'><label id='A1E8743D5C'><select id='A1E8743D5C'><dt id='A1E8743D5C'><span id='A1E8743D5C'></span></dt></select></label></b><u id='A1E8743D5C'></u>
          <i id='A1E8743D5C'><strike id='A1E8743D5C'><tt id='A1E8743D5C'><pre id='A1E8743D5C'></pre></tt></strike></i>

          Home / explore / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:1198
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In